Titre : Cônes de croissance

Cônes de croissance : Questions médicales fréquentes

Termes MeSH sélectionnés :

Logistic Models
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cônes de croissance : Questions médicales les plus fréquentes", "headline": "Cônes de croissance : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cônes de croissance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-08", "dateModified": "2025-04-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cônes de croissance" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Axones", "url": "https://questionsmedicales.fr/mesh/D001369", "about": { "@type": "MedicalCondition", "name": "Axones", "code": { "@type": "MedicalCode", "code": "D001369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145" } } }, "about": { "@type": "MedicalCondition", "name": "Cônes de croissance", "alternateName": "Growth Cones", "code": { "@type": "MedicalCode", "code": "D020439", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michihiro Igarashi", "url": "https://questionsmedicales.fr/author/Michihiro%20Igarashi", "affiliation": { "@type": "Organization", "name": "Department of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, 951-8510, Japan." } }, { "@type": "Person", "name": "Daniel M Suter", "url": "https://questionsmedicales.fr/author/Daniel%20M%20Suter", "affiliation": { "@type": "Organization", "name": "Department of Biological Sciences, Purdue University, West Lafayette, IN, USA. dsuter@purdue.edu." } }, { "@type": "Person", "name": "Yimin Zou", "url": "https://questionsmedicales.fr/author/Yimin%20Zou", "affiliation": { "@type": "Organization", "name": "Neurobiology Section, Biological Sciences Division, University of California San Diego, La Jolla, CA 92093 yzou@ucsd.edu." } }, { "@type": "Person", "name": "Jeffrey van Haren", "url": "https://questionsmedicales.fr/author/Jeffrey%20van%20Haren", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Snehal S Mahadik", "url": "https://questionsmedicales.fr/author/Snehal%20S%20Mahadik", "affiliation": { "@type": "Organization", "name": "Program in Molecular, Cellular, and Developmental Biology, Department of Molecular Biosciences, The University of Kansas, 1200 Sunnyside Avenue, 5049 Haworth Hall, Lawrence, KS 66045." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Analysis of environmental variables and deforestation in the amazon using logistical regression models.", "datePublished": "2024-09-09", "url": "https://questionsmedicales.fr/article/39251519", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10661-024-13086-z" } }, { "@type": "ScholarlyArticle", "name": "Design and Implementation of Smart Community Big Data Dynamic Analysis Model Based on Logistic Regression Model.", "datePublished": "2022-06-22", "url": "https://questionsmedicales.fr/article/35785068", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/4038084" } }, { "@type": "ScholarlyArticle", "name": "Prediction of protein aggregation propensity employing SqFt-based logistic regression model.", "datePublished": "2023-07-27", "url": "https://questionsmedicales.fr/article/37516225", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijbiomac.2023.126036" } }, { "@type": "ScholarlyArticle", "name": "Multiple logistic regression model to predict bile leak associated with subtotal cholecystectomy.", "datePublished": "2023-04-04", "url": "https://questionsmedicales.fr/article/37016083", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00464-023-10049-2" } }, { "@type": "ScholarlyArticle", "name": "A noble extended stochastic logistic model for cell proliferation with density-dependent parameters.", "datePublished": "2022-05-30", "url": "https://questionsmedicales.fr/article/35637247", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-12719-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Neurones", "item": "https://questionsmedicales.fr/mesh/D009474" }, { "@type": "ListItem", "position": 4, "name": "Neurofibres", "item": "https://questionsmedicales.fr/mesh/D009412" }, { "@type": "ListItem", "position": 5, "name": "Axones", "item": "https://questionsmedicales.fr/mesh/D001369" }, { "@type": "ListItem", "position": 6, "name": "Cônes de croissance", "item": "https://questionsmedicales.fr/mesh/D020439" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cônes de croissance - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cônes de croissance", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cônes de croissance", "description": "Comment identifier un cône de croissance ?\nQuels tests sont utilisés pour étudier les cônes de croissance ?\nLes cônes de croissance peuvent-ils être visualisés in vivo ?\nQuels marqueurs sont utilisés pour les cônes de croissance ?\nPeut-on évaluer la fonction des cônes de croissance ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Logistic+Models&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cônes de croissance", "description": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?\nLes cônes de croissance affectent-ils le comportement ?\nComment les cônes de croissance sont-ils liés à la douleur ?\nLes troubles de la croissance neuronale causent-ils des symptômes physiques ?\nLes symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Logistic+Models&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cônes de croissance", "description": "Peut-on prévenir les anomalies des cônes de croissance ?\nQuel rôle joue l'environnement dans le développement des cônes de croissance ?\nLes facteurs génétiques influencent-ils les cônes de croissance ?\nComment le stress maternel impacte-t-il le développement neuronal ?\nLes vaccinations influencent-elles le développement neuronal ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Logistic+Models&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cônes de croissance", "description": "Quels traitements existent pour les troubles liés aux cônes de croissance ?\nLa chirurgie peut-elle corriger des anomalies des cônes de croissance ?\nLes médicaments peuvent-ils aider à la régénération des cônes de croissance ?\nY a-t-il des thérapies innovantes pour les cônes de croissance ?\nComment la réhabilitation aide-t-elle les patients ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Logistic+Models&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cônes de croissance", "description": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être prévenues ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Logistic+Models&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cônes de croissance", "description": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?\nLe tabagisme maternel est-il un facteur de risque ?\nL'exposition à des toxines affecte-t-elle les cônes de croissance ?\nLes troubles génétiques augmentent-ils le risque ?\nLe manque de soins prénatals est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Logistic+Models&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un cône de croissance ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'observation microscopique des neurones en culture permet d'identifier les cônes de croissance." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier les cônes de croissance ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques comme la microscopie à fluorescence et l'immunohistochimie sont couramment utilisées." } }, { "@type": "Question", "name": "Les cônes de croissance peuvent-ils être visualisés in vivo ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques d'imagerie avancées permettent de visualiser les cônes de croissance in vivo." } }, { "@type": "Question", "name": "Quels marqueurs sont utilisés pour les cônes de croissance ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme la tubuline et la protéine GAP-43 sont souvent utilisés pour les identifier." } }, { "@type": "Question", "name": "Peut-on évaluer la fonction des cônes de croissance ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests fonctionnels mesurent la capacité des cônes à diriger la croissance axonale." } }, { "@type": "Question", "name": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies dans la croissance neuronale peuvent entraîner des troubles neurologiques." } }, { "@type": "Question", "name": "Les cônes de croissance affectent-ils le comportement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans leur développement peuvent influencer le comportement et les fonctions cognitives." } }, { "@type": "Question", "name": "Comment les cônes de croissance sont-ils liés à la douleur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des cônes de croissance mal orientés peuvent contribuer à des douleurs neuropathiques." } }, { "@type": "Question", "name": "Les troubles de la croissance neuronale causent-ils des symptômes physiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles peuvent entraîner des déficits moteurs ou sensoriels selon la région affectée." } }, { "@type": "Question", "name": "Les symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais des anomalies peuvent augmenter le risque de troubles neurologiques." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies des cônes de croissance ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies peuvent être évitées par une bonne nutrition et des soins prénatals." } }, { "@type": "Question", "name": "Quel rôle joue l'environnement dans le développement des cônes de croissance ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement enrichi peut favoriser un développement neuronal sain et fonctionnel." } }, { "@type": "Question", "name": "Les facteurs génétiques influencent-ils les cônes de croissance ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mutations génétiques peuvent affecter le développement et la fonction des cônes." } }, { "@type": "Question", "name": "Comment le stress maternel impacte-t-il le développement neuronal ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le stress maternel peut nuire au développement des cônes de croissance et à la santé neuronale." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles le développement neuronal ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne nuisent pas au développement neuronal et sont essentielles pour la santé." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles liés aux cônes de croissance ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie physique, la médication et la rééducation neurologique." } }, { "@type": "Question", "name": "La chirurgie peut-elle corriger des anomalies des cônes de croissance ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la chirurgie peut être envisagée pour corriger des malformations structurelles." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à la régénération des cônes de croissance ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments favorisent la régénération axonale et la plasticité neuronale." } }, { "@type": "Question", "name": "Y a-t-il des thérapies innovantes pour les cônes de croissance ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et cellulaires sont en cours d'étude pour améliorer la régénération neuronale." } }, { "@type": "Question", "name": "Comment la réhabilitation aide-t-elle les patients ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La réhabilitation aide à restaurer les fonctions perdues et à améliorer la qualité de vie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles neurologiques, des déficits moteurs et des douleurs chroniques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être atténuées par des traitements précoces et appropriés." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications neurologiques sont courantes chez les patients avec des anomalies des cônes." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévenues par un suivi médical régulier et des interventions précoces." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections prénatales et des toxines environnementales." } }, { "@type": "Question", "name": "Le tabagisme maternel est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme pendant la grossesse augmente le risque d'anomalies du développement neuronal." } }, { "@type": "Question", "name": "L'exposition à des toxines affecte-t-elle les cônes de croissance ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut nuire au développement neuronal." } }, { "@type": "Question", "name": "Les troubles génétiques augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles génétiques sont associés à des anomalies dans le développement des cônes." } }, { "@type": "Question", "name": "Le manque de soins prénatals est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un manque de soins prénatals peut augmenter le risque de complications neurologiques." } } ] } ] }

Sources (10000 au total)

Multiple logistic regression model to predict bile leak associated with subtotal cholecystectomy.

There are no prediction models for bile leakage associated with subtotal cholecystectomy (STC). Therefore, this study aimed to generate a multivariable prediction model for post-STC bile leakage and e... We analysed prospectively managed data of patients who underwent STC by a single consultant surgeon between 14 May 2013 and 21 December 2021. STC was schematised into four variants with five subvarian... A total of 81 patients underwent the STC procedure. Twenty-eight patients (35%) developed bile leakage. Of these, 18 patients (64%) required secondary surgical intervention. Multivariable logistic reg... Open-tract STC and acute cholecystitis are the most reliable predictors of bile leakage associated with STC. Future prospective, multicentre studies with higher statistical power are needed to generat...

Combining proteomic markers to construct a logistic regression model for polycystic ovary syndrome.

Proteomics technology has been used in various fields in recent years for the Q6 exploration of novel markers and the study of disease pathogenesis, and has become one of the most important tools for ... In our previous study we used DIA proteomics to screen for proteins that were significant in 31 PCOS patients compared to women of normal reproductive age. In this study, we used logistic regression a... We constructed a logistic model using these protein markers, where HIST1H4A (OR=1.037) was an independent risk factor for polycystic ovary syndrome and TREML1 (OR=0.976) were protective factors for th... Our study is the first to use proteomic results with clinical biochemical data to construct a logistic regression model, and the model is consistent. However, our study still needs a more complete sam...

Establishment of HIV-negative neurosyphilis risk score model based on logistic regression.

To establish the risk scoring model for HIV-negative neurosyphilis (NS) patients and to optimize the lumbar puncture strategy.... From 2016 to 2021, clinical information on 319 syphilis patients was gathered. Multivariate logistic regression was used to examine the independent risk factors in NS patients who tested negative for ... There were statistically significant differences between HIV-negative NS and non-neurosyphilis (NNS) patients in the following factors. These included age, gender, neuropsychiatric symptoms (including... The risk scoring model in this study can classify the risk of neurosyphilis in syphilis patients, optimize the lumbar puncture strategy to a certain extent, and provide ideas for the clinical diagnosi...

Adjustment for baseline characteristics in randomized trials using logistic regression: sample-based model versus true model.

Adjustment for baseline prognostic factors in randomized clinical trials is usually performed by means of sample-based regression models. Sample-based models may be incorrect due to overfitting. To as... We conducted a simulation study using samples drawn from a "population" in which both the treatment effect and the effect of the potential confounder were specified. The outcome variable was binary. U... Sample-based adjustment models yielded more biased estimates of the treatment effect than adjustment models that used the true confounder effect but had similar variance, accuracy, power, and type 1 e... Sample-based adjustment yields similar results to exact adjustment in estimating the treatment effect. Sample-based adjustment is preferable to no adjustment....

A calibration and uncertainty quantification analysis of classical, fractional and multiscale logistic models of tumour growth.

The validation of mathematical models of tumour growth is frequently hampered by the lack of sufficient experimental data, resulting in qualitative rather than quantitative studies. Recent approaches ... The multiscale expansion of logistic growth models was performed by coupling gene expression profiles to the cell death rates. State-of-the-art Bayesian inference, likelihood maximisation and uncertai... The results suggest that the classical single-cell population model (SCPM) was the best fit for the untreated and low-dose treatment conditions, while the multiscale model with a cell death rate symme... Overall, the present study demonstrates that model performance can be improved by incorporating multiscale measurements of tumour growth when high-dose treatment is involved....

Minimum sample size for developing a multivariable prediction model using multinomial logistic regression.

Multinomial logistic regression models allow one to predict the risk of a categorical outcome with > 2 categories. When developing such a model, researchers should ensure the number of participants (... The first criterion aims to minimise the model overfitting. The second aims to minimise the difference between the observed and adjusted... We tested the performance of the proposed criteria (i) through a simulation study and found that it resulted in the desired level of overfitting. Criterion (ii) and (iii) were natural extensions from ... We illustrated how to implement the sample size criteria through a worked example considering the development of a multinomial risk prediction model for tumour type when presented with an ovarian mass...